bell
The current prices are delayed by 15 mins, login to check live prices.
Valiant Laboratories Ltd share price logo

Valiant Laboratories Ltd

(VALIANTLAB)

₹112.670.91%

as on 04:01PM, 24 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Valiant Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹112.1
    Day's Price Range
    ₹115.96
  • 52 Week's Low

    52 Week's High

    ₹100.2
    52-Week Price Range
    ₹214.95
1 Month Return-0.15 %
3 Month Return-4.11 %
1 Year Return-35.56 %
Previous Close₹113.71
Open₹114.90
Volume53.36K
Upper Circuit-
Lower Circuit-
Market Cap₹489.55Cr

Valiant Laboratories Ltd Key Statistics

P/E Ratio-47.74
PEG Ratio4.33
Market Cap₹489.55 Cr
P/B Ratio2.67
EPS0.07
Dividend Yield0
SectorPharmaceuticals
ROE-1.7

Valiant Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹489.55 Cr-6.76%0.60₹29 Cr₹182 Cr
NA₹887.00 Cr264.92%0.91₹55 Cr₹575 Cr
NA₹2,407.31 Cr159.02%0.62₹43 Cr₹381 Cr
NA₹930.38 Cr681.88%0.65₹23 Cr₹307 Cr
NA₹519.70 Cr31.31%0.56₹13 Cr₹154 Cr

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17 1980. The said Partnership Firm M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16 2021 issued by the Central Registration Centre Registrar of Companies.The Company is an Active Pharmaceutical Ingredient API / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually commenced manufacturing of Paracetamol by late 1982. Paracetamol Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2 is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization WHO. Paracetamol has several applications such as usage in treatment of headaches muscle aches arthritis back aches toothaches cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form regular tablets effervescent tablets injection suppository and other forms. Paracetamol is often found combined with other drugs in many over the counter OTC allergy medications cold medications sleep medications pain relievers and other products. Presently the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area Boisar in the State of Maharashtra with an annual installed capacity of 9000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area Palghar Maharashtra the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora Director and Dhanvallabh Ventures LLP DVL. In July 2022 the Company formed its wholly owned subsidiary Valiant Advanced Sciences Private Limited VASPL to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11556000 Equity Shares through fresh issue..

Share Price: ₹112.67 per share as on 24 Dec, 2024 04:01 PM
Market Capitalisation: ₹489.55Cr as of today
Revenue: ₹21.48Cr as on September 2024 (Q3 24)
Net Profit: ₹-4.74Cr as on September 2024 (Q3 24)
Listing date: 06 Oct, 2023
Chairperson Name: Velji Gogri
OrganisationValiant Laboratories Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Valiant Laboratories Ltd

  • Valiant Laboratories Ltd Worth Watching with High ROE and Low Debt-to-Equity Ratio - 06 Apr, 2024

    Valiant Laboratories Limited has a return on equity (ROE) of 24%, which is higher than the industry average of 13%. The company also has a low debt to equity ratio of 0.58, suggesting it's worth watching. However, other factors such as future profit growth and investment requirements should be considered before investing.

Insights on Valiant Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 21.7 Cr → 24.84 Cr (in ₹), with an average increase of 12.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 23.17% to 25.06% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.94% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.89% to 0.00% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -0.51 Cr → -4.74 Cr (in ₹), with an average decrease of 829.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, VALIANTLAB stock has moved down by -35.6%

Valiant Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹59.55Cr (-)₹40.52Cr (↓31.96%)₹30.59Cr (↓24.51%)₹18.88Cr (↓38.28%)₹21.48Cr (↑13.77%)
Net Income₹0.79Cr (-)-₹3.50Cr (↓543.04%)-₹1.24Cr (↓64.57%)-₹0.51Cr (↓58.87%)-₹4.74Cr (↑829.41%)
Net Profit Margin1.33% (-)-8.64% (↓749.62%)-4.05% (↓53.13%)-2.70% (↓33.33%)-22.07% (↑717.41%)
Value in ₹ crore
Details2021202220232024
Total Assets₹106.32Cr (-)₹181.80Cr (↑70.99%)₹212.86Cr (↑17.08%)₹325.42Cr (↑52.88%)
Total Liabilities₹17.74Cr (-)₹110.34Cr (↑521.98%)₹112.37Cr (↑1.84%)₹88.54Cr (↓21.21%)
Value in ₹ crore
Details2021202220232024
Operating Cash Flow₹9.11Cr (-)₹2.25Cr (↓75.30%)₹22.96Cr (↑920.44%)₹48.78Cr (↑112.46%)

Valiant Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
74.94%
0.00
Foreign Institutions
0%
-100.00
Mutual Funds
0%
0.00
Retail Investors
25.06%
8.17
Others
0%
0.00

Valiant Laboratories Ltd Key Indicators

Details202220232024
Return On Equity %34.3733.73-1.7
Details2024
Return On Assets %0.1
Details2024
Book Value Per Share (₹)54.51
Details2024
Earning Per Share (₹)0.07

Valiant Laboratories Ltd Valuation

Valiant Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-147.86x)

July 11, 2024

Today (-47.74x)

December 24, 2024

Industry (56.56x)

December 24, 2024

Highest (413.29x)

April 10, 2024

LowHigh

Valiant Laboratories Ltd Earnings and Dividends

  • Valiant Laboratories Ltd Earnings Results

    Valiant Laboratories Ltd’s net profit fell -700% since last year same period to ₹-4.74Cr in the Q2 2024-2025. On a quarterly growth basis, Valiant Laboratories Ltd has generated -829.41% fall in its net profits since last 3-months.

    Read More about Earnings Results

Valiant Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Valiant Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Valiant Laboratories Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Valiant Laboratories Ltd shares.

Valiant Laboratories Ltd (VALIANTLAB) share price today is ₹112.67

Valiant Laboratories Ltd is listed on NSE

Valiant Laboratories Ltd is listed on BSE

  • Today’s highest price of Valiant Laboratories Ltd is ₹115.96.
  • Today’s lowest price of Valiant Laboratories Ltd is ₹112.1.

PE Ratio of Valiant Laboratories Ltd is -47.74

PE ratio = Valiant Laboratories Ltd Market price per share / Valiant Laboratories Ltd Earnings per share

Today’s traded volume of Valiant Laboratories Ltd(VALIANTLAB) is 53.36K.

Today’s market capitalisation of Valiant Laboratories Ltd(VALIANTLAB) is ₹489.55Cr.

Valiant Laboratories Ltd(VALIANTLABPrice
52 Week High
₹214.95
52 Week Low
₹100.2

Valiant Laboratories Ltd(VALIANTLAB) share price is ₹112.67. It is down -47.58% from its 52 Week High price of ₹214.95

Valiant Laboratories Ltd(VALIANTLAB) share price is ₹112.67. It is up 12.45% from its 52 Week Low price of ₹100.2

Valiant Laboratories Ltd(VALIANTLABReturns
1 Day Returns
-1.04%
1 Month Returns
-0.15%
3 Month Returns
-4.11%
1 Year Returns
-35.56%